WO1999058638A3 - Sequences of tt viruses for use in diagnosis, prevention and treatment of ttv infections - Google Patents
Sequences of tt viruses for use in diagnosis, prevention and treatment of ttv infections Download PDFInfo
- Publication number
- WO1999058638A3 WO1999058638A3 PCT/EP1999/003183 EP9903183W WO9958638A3 WO 1999058638 A3 WO1999058638 A3 WO 1999058638A3 EP 9903183 W EP9903183 W EP 9903183W WO 9958638 A3 WO9958638 A3 WO 9958638A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- ttv
- sequences
- prevention
- treatment
- viruses
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/00022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU42592/99A AU4259299A (en) | 1998-05-13 | 1999-05-10 | New sequences of tt viruses for use in diagnosis, prevention and treatment of ttv infections |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP98870109.0 | 1998-05-13 | ||
EP98870109 | 1998-05-13 | ||
EP98870235.3 | 1998-11-03 | ||
EP98870235 | 1998-11-03 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1999058638A2 WO1999058638A2 (en) | 1999-11-18 |
WO1999058638A3 true WO1999058638A3 (en) | 2000-04-06 |
Family
ID=26152261
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP1999/003183 WO1999058638A2 (en) | 1998-05-13 | 1999-05-10 | Sequences of tt viruses for use in diagnosis, prevention and treatment of ttv infections |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU4259299A (en) |
WO (1) | WO1999058638A2 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TNSN99210A1 (en) * | 1998-11-10 | 2005-11-10 | Diasorin S R L | IDENTIFICATION OF SEN VIRUS GENOTYPES |
US6395472B1 (en) * | 1999-02-05 | 2002-05-28 | Abbott Laboratories | Methods of utilizing the TT virus |
SE9901601D0 (en) * | 1999-05-04 | 1999-05-04 | Tripep Ab | Peptides from the TT virus sequence and monospecific antibodies binding to the TT virus |
FR2808277A1 (en) * | 2000-04-28 | 2001-11-02 | Bio Merieux | TTV POLYPEPTIDE, NUCLEIC ACID ENCODING THIS POLYPEPTIDE AND USES |
PL365842A1 (en) * | 2000-05-05 | 2005-01-10 | F.Hoffmann-La Roche Ag | Sentinel virus ii |
WO2001085771A1 (en) * | 2000-05-11 | 2001-11-15 | Eisai Co., Ltd. | Novel ttv-related virus s-ttv |
DE10144346A1 (en) * | 2001-09-10 | 2003-04-03 | Deutsches Krebsforsch | TT virus sequences in human tumor tissues, means for their detection and tumor therapy |
JP2012505653A (en) * | 2008-10-16 | 2012-03-08 | ファイザー・インク | Torque Tenovirus (TTV) Isolates and Compositions |
-
1999
- 1999-05-10 WO PCT/EP1999/003183 patent/WO1999058638A2/en active Application Filing
- 1999-05-10 AU AU42592/99A patent/AU4259299A/en not_active Abandoned
Non-Patent Citations (5)
Title |
---|
EMBL DATABASE vrl SEQ ID AF060547: TT virus strain BT/3, unknown gene. 11 may 1998 * |
NISHIZAWA T ET AL.: "A novel DNA virus (TTV) associated with elevated transaminase levels in posttransfusion hepatitis of unknown etiology", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, vol. 241, no. 1, 8 December 1997 (1997-12-08), ORLANDO, FL US, pages 92 - 97, XP002080817 * |
OKAMOTO H ET AL.: "Molecular cloning and characterization of a novel DNA virus (TTV) associated with posttransfusion hepatitis of unknown etiology", HEPATOLOGY RESEARCH, vol. 10, no. 1, January 1998 (1998-01-01), pages 1 - 16, XP002080816 * |
SIMMONDS P ET AL.: "Detection of a novel DNA virus (TTV) in blood donors and blood products.", LANCET THE, vol. 352, 18 July 1998 (1998-07-18), LONDON GB, pages 191 - 197, XP002128309 * |
TANAKA Y ET AL.: "New genotypes of TT virus (TTV) and a genotypeing assay based on restriction fragment length polymorphism", FEBS LETTERS, vol. 437, no. 3, 23 October 1998 (1998-10-23), AMSTERDAM NL, pages 201 - 206, XP002128308 * |
Also Published As
Publication number | Publication date |
---|---|
WO1999058638A2 (en) | 1999-11-18 |
AU4259299A (en) | 1999-11-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007048857A8 (en) | Use of tgf-$g(b)1 inhibitor peptides in the preparation of an immune response modulating agent | |
WO1995021601A3 (en) | Kallikrein-inhibiting 'kunitz domain' proteins and analogues thereof | |
EP2258383A3 (en) | Antigenic peptides derived from telomerase | |
EP1731166A3 (en) | Streptococcus pneumoniae proteins and vaccines | |
MXPA05007711A (en) | Cop 1 for treatment of inflammatory bowel diseases. | |
WO2002090502A3 (en) | Highly conserved proteins from gram-positive bacteria | |
WO1999058638A3 (en) | Sequences of tt viruses for use in diagnosis, prevention and treatment of ttv infections | |
WO1999004011A3 (en) | Hiv-1 group o antigens and uses thereof | |
WO2002085937A3 (en) | Inflammation-specific peptides and the uses thereof | |
EP1501936A4 (en) | Cytokine protein family | |
WO1999058639A3 (en) | Structural proteins of fish pancreatic disease virus and uses thereof | |
FR2828405B1 (en) | ANTI-CORONAVIRUS VACCINE | |
WO1999051256A3 (en) | Use of l-glu-l-trp in the treatment of hiv infection | |
SE9901601D0 (en) | Peptides from the TT virus sequence and monospecific antibodies binding to the TT virus | |
WO2000032629A3 (en) | Antiviral peptides | |
WO2001053347A3 (en) | Nphs2 gene involved in the cortico-resistant neprhotic syndrome, protein encoded by said gene and diagnostic and therapeutic uses | |
WO1998023752A3 (en) | Papilloma viruses, agents for detecting the same and for treating diseases caused by such viruses | |
EP1757618A3 (en) | Angiogenesis-associated proteins, and nucleic acids encoding the same | |
WO2001004145A3 (en) | Glutx polypeptide family and nucleic acids encoding same | |
WO2001036635A3 (en) | Neurite outgrowth-promoting factor homologue and nucleic acids encoding same | |
WO2000052147A3 (en) | Bacterial prolyl peptidases and methods of use | |
WO2002079240A3 (en) | Intimins for the prevention or treatment of infections: i | |
WO1998001550A3 (en) | Vaccine against gastro-intestinal nematodes | |
EP2025754A3 (en) | Moraxella (Branhamella) catarrhalis antigens | |
WO2002029023A8 (en) | Nicastrin protein |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: KR |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase |